These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1254383)

  • 1. Effect of tuberculostatic agents on the response of serum growth hormone and immunoreactive insulin to intravenous tolbutamide, and on the half-life of tolbutamide.
    Syvälahti E; Pihlajamäki K; Iisalo E
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):83-9. PubMed ID: 1254383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum growth hormone, serum immunoreactive insulin and blood glucose response to oral and intravenous diazepam in man.
    Syvälahti EK; Kanto JH
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):74-82. PubMed ID: 1100541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute suppressive effect of human growth hormone on insulin release induced by glucagon and tolbutamide in man.
    Adamson U; Cerasi E
    Diabete Metab; 1975 Mar; 1():51-6. PubMed ID: 1234067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of indomethacin on serum growth hormone, immunoreactive insulin, and blood glucose levels of young adult males.
    Syvälahti EK
    Int J Clin Pharmacol; 1974 Sep; 10(2):111-6. PubMed ID: 4448551
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma insulin, growth hormone, and blood sugar during exercise in man.
    Sawhney RC; Malhotra AS; Gupta RB
    Indian J Physiol Pharmacol; 1982; 26(2):119-24. PubMed ID: 6754602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose.
    Boden G; Soeldner JS; Gleason RE; Marble A
    J Clin Invest; 1968 Apr; 47(4):729-39. PubMed ID: 5641614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of tolbutamide and chloramphenicol in diabetic patients.
    Brunová E; Slabochová Z; Platilová H; Pavlik F; Grafnetterová J; Dvorácek K
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):7-12. PubMed ID: 838527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in carbohydrate metabolism during the administration of progestational hormones].
    Vela P
    Rev Chil Obstet Ginecol; 1970; 35(2):40-9. PubMed ID: 5531975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
    Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuberculosis therapy and enzyme induction in man.
    Larousse C; Le Normand Y; Kergueris MF; Veyrac MJ; Chailleux E; Ordronneau J; Moigneteau C
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):163-8. PubMed ID: 7380590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum immunoreactive insulin level and tolbutamide concentration in the peripheral blood after a single oral dose of tolbutamide in man.
    Kawanishi K; Goto A; Ishida T
    Acta Med Okayama; 1973 Dec; 27(5):177-83. PubMed ID: 4273584
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery.
    Valera Mora ME; Manco M; Capristo E; Guidone C; Iaconelli A; Gniuli D; Rosa G; Calvani M; Mingrone G
    Obesity (Silver Spring); 2007 Aug; 15(8):2012-8. PubMed ID: 17712119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
    Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum growth hormone, serum immunoreactive insulin and blood glucose response to intravenous tolbutamide in postmenopausal women with and without natural oestrogen therapy.
    Syvälahti E; Erkkola R; Punnonen R; Rauramo L
    Acta Pharmacol Toxicol (Copenh); 1976 Mar; 38(3):177-85. PubMed ID: 988954
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes mellitus. Distinguishing between patients receiving insulin and those requiring insulin therapy.
    Mahler RJ
    West J Med; 1974 May; 120(5):358-62. PubMed ID: 4839480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide.
    Park JY; Kim KA; Park PW; Park CW; Shin JG
    Clin Pharmacol Ther; 2003 Oct; 74(4):334-40. PubMed ID: 14534520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone and insulin secretion in oophorectomized women.
    Syvälahti E; Erkkola R; Iisalo E; Punnonen R; Rauramo L
    Horm Metab Res; 1975 Sep; 7(5):438-9. PubMed ID: 1183926
    [No Abstract]   [Full Text] [Related]  

  • 19. Growth hormone secretion in diffuse idiopathic skeletal hyperostosis.
    Altomonte L; Zoli A; Mirone L; Marchese G; Scolieri P; Barini A; Magarò M
    Ann Ital Med Int; 1992; 7(1):30-3. PubMed ID: 1524945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter: Rifampicin and drug metabolism.
    Syvälahti EK; Pihlajamäki KK; Iisalo EJ
    Lancet; 1974 Jul; 2(7874):232-3. PubMed ID: 4135664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.